Skip to main content

Table 1 Baseline characteristics of the study population

From: A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population – the Malmö preventive project study

 

Total sample

Subjects without LVH

Subjects with LVH

N

968

820

148

Sex (% women)

30.5

30.6

29.7

Age (years)

67.1 (±5.7)

66.7 (±5.7)

69.4 (±5.2)

Systolic BP (mmHg)

146.0 (±19.3)

145.1 (±19.0)

150.8 (±20.2)

Diastolic BP (mmHg)

84.5 (±10.2)

84.2 (±10.0)

86.6 (±11.3)

Antihypertensive and/or cardioprotective treatment (%)

41.3

37.8

60.8

Hypertension (%)

74.5

71.5

91.1

BMI

27.3 (±3.8)

26.9 (±3.4)

29.8 (±4.8)

FPG (mmol/l)*

5.8 [0.9]

5.8 [1.0]

6.1 [1.0]

  1. Data are expressed as mean (±SD) or median [interquartile range (IQR)]*. BP blood pressure, BMI body mass index, FPG fasting plasma glucose.